on coronary computed tomography angiography (CCTA) also showed the additive value of CCTA-derived adverse plaque characteristics (APC) and further supports the importance of assessing plaque characteristics in the prediction of future cardiovascular events. [11] [12] [13] Recently, 18 F-sodium fluoride ( 18 F-NaF) positron-emission tomography (PET) has been introduced as a potential noninvasive imaging tool to identify and localize plaque with high-risk characteristics in patients with coronary artery disease. 12, 14 As 18 F-NaF incorporates into the hydroxyapatite crystals, localized 18 F-NaF activity in coronary plaque suggests the early and most active stage of vascular inflammation and microcalcification. 12 Although previous studies showed promising results, the clinical relevance of 18 F-NaF PET uptake has not been fully investigated with multimodality imaging and invasive and noninvasive lesion characteristics to define high-risk plaque.
In this regard, the current study sought to evaluate the clinical relevance of 18 F-NaF uptake using intravascular ultrasound (IVUS), optical coherence tomography (OCT), and CCTA in defining plaques with high-risk characteristics in patients with coronary artery disease.
Methods

Study Population
Between March 2015 and October 2015, 51 patients (93 intermediate stenoses) with suspected coronary artery disease who underwent 18 F-NaF PET before invasive coronary angiography were enrolled from the Seoul National University Hospital. During invasive coronary angiography, IVUS and OCT were performed for stenoses of 30% to 80% stenosis. Patients with acute myocardial infarction, those without angiographic stenosis (<30%), and inadequate image quality of IVUS or OCT were excluded ( Figure I in the Data Supplement). The study protocol was approved by the institutional review board and was in accordance with the Declaration of Helsinki. All patients provided written informed consent before enrollment.
F-NaF PET
All patients underwent 18 F-NaF PET before invasive coronary angiography. The electrocardiography-gated PET images were obtained 60 minutes after injection of 3 MBq/kg of 18 F-NaF by list mode using a dedicated PET/CT scanner (Biograph 40 TruePoint; Siemens Healthcare, Germany). The 18 F-NaF PET images were reconstructed in 4 frames and fused with the nonenhanced CT images. The 18 F-NaF PET images of diastolic phases (frames of 50% to 75% and 75% to 100% of the R-R intervals) were analyzed by an independent observer blinded to clinical information using a vendor-supplied analysis tool (Synog.via; Siemens Healthcare, Germany). Two-dimensional circular regions of interest were drawn with tracking all major epicardial coronary arteries on every 3-mm axial slices. The maximum standard uptake value (the decay-corrected tissue concentration of the tracer divided by the injected dose per body weight) was measured and corrected for blood pool activity measured in the inferior vena cava to provide tissue-to-background ratio (TBR) measurements ( Figure II in the Data Supplement). 12 The highest TBR value measured on the 2 diastolic-phase images was adopted for final analysis. Qualitative assessment for 18 F-NaF uptakes was also performed, and uptake was classified into not detectable, mild (<25% higher than reference lesion), moderate (25%-50% higher than reference lesion), and marked degree (>50% higher than reference lesion; Figure 1 ). Any plaque with more than mild uptake was categorized into 18 F-NaF-positive lesions.
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CCTA and Analysis of APC
CCTA images were obtained in accordance with the Society of Cardiovascular Computed Tomography Guidelines on performance of CCTA, with 64 or higher detector row scanner platforms. 15 The CCTA images were analyzed at a core laboratory (Severance Cardiovascular Hospital) in a blinded fashion. The presence of APC, which were defined as any of given characteristics, low-attenuation plaque, positive remodeling, napkin-ring sign, and spotty calcification, was assessed in each lesion by an independent observer, according to the definitions from previous studies. 6, 11, 16 Briefly, plaque density was assessed semiautomatically using a dedicated cardiac workstation (Intellispace Portal; Philips Healthcare). 16 Lesions were classified according to individual APC: low-attenuation plaque (average density≤30 HU), positive remodeling (remodeling index≥1.1), spotty calcification (average density>130 HU and diameter<3 mm), and napkin-ring sign (ring-like attenuation pattern with peripheral high attenuation tissue surrounding a central lower attenuation portion).
16-18
Invasive Coronary Angiography and Intracoronary Imaging
Selective invasive coronary angiography was performed using standard techniques. All angiograms were obtained after intracoronary bolus injection of 100 to 200 μg of nitroglycerin. All angiograms were analyzed at a core laboratory (Seoul National University Hospital) in a blinded fashion. Quantitative coronary angiography was performed in optimal projections with validated software (CAAS II; Pie Medical System, Maastricht, The Netherlands). Minimum lumen diameter, reference vessel size, and lesion length were measured, and percent diameter stenosis was calculated.
IVUS images were obtained after intracoronary administration of 200 μg of nitroglycerin using commercially available systems (OptiCross; Boston Scientific). IVUS images were acquired with automated pullback at 0.5 mm/s and were analyzed using commercially available software (Echoplaque 4.0; INDEC Medical System, Santa Clara, CA) at a core laboratory (Seoul National University Hospital) in a blinded fashion. Evaluation of 2-and 3-dimensional lesion morphology and other measurements of IVUS images were performed according to the American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies. 19, 20 Measured quantitative IVUS parameters were external elastic membrane (EEM) area, lumen cross-sectional area (CSA), minimum lumen area (MLA), and plaque plus media (P+M) area. Plaque burden was calculated as: [(P+M CSA)/(EEM CSA)]×100. The remodeling index was calculated as (EEM CSA at the MLA site)/(average of the proximal and distal reference EEM CSA), and positive remodeling was defined as a plaque with remodeling index ≥1.1. IVUS-defined high-risk plaque was defined as plaques with both posterior attenuation and positive remodeling.
OCT images were obtained using a commercially available catheter (Dragon Fly; St. Jude Medical). All OCT data were digitally stored and transferred to a core laboratory (Wakayama Medical University), where they were analyzed by an independent investigator who was blinded to the clinical presentation. OCT images were analyzed with previously validated criteria for plaque characterization. 21 The presence of macrophage infiltration, microvessels, or thincap fibroatheroma (TCFA) was analyzed. Macrophage infiltration was defined as signal-intense punctuate regions with strong signal attenuation, and maximum arc of macrophage was measured. 22 The presence of microvessel was defined as reported previously. 23 Plaque characterization was classified into 3 types: fibrous, fibrocalcific, or lipid-rich plaque. Fibrous plaque was defined as a signal-rich region with homogeneous scattering. 21, 24 When lipid was present in ≥2 quadrants in any of the images within a plaque, the plaque was classified as a lipid-rich plaque. Fibrous cap thickness of lipid-rich plaques was measured 3× at its thinnest part, and the averaged value was used. 25 A lipid-rich plaque with a fibrous cap thickness ≤65 μm was defined as a TCFA. 25 OCT-defined high-risk plaque was defined as a plaque with TCFA, macrophage(s), or microvessel(s).
To compare invasive and noninvasive imaging-derived plaque characteristics and 18 F-NaF PET findings, all the IVUS, OCT, CCTA, and 18 F-NaF PET-CT images were coregistered. Utilizing major side branches as index markers, images were coregistered with the consideration of the distance along the longitudinal axis. Other anatomic landmarks such as calcification, location of stenosis, or luminal configuration were additionally used for this coregistration process.
Statistical Analysis
Study Hypothesis and Sample Size Calculation
The primary analysis was the comparison of 18 F-NaF TBR between plaque with or without OCT-defined high-risk characteristics. To calculate required sample size, prespecified interim analysis was performed after enrollment of 30 patients. In these patients, the difference of 18 F-NaF TBR was 0.375 between plaques with or without OCT-defined high-risk characteristics. With consideration of average lesion count in 1 patient and the rate of OCT unavailability (10%), a total of 56 patients were planned to be enrolled to prove the potential difference of 18 F-NaF TBR between plaque with or without OCTdefined high-risk characteristics with 90% power and 2-sided P<0.05.
Analysis Methods
Categorical variables were presented as numbers and relative frequencies (percentages), and continuous variables as means and SDs, whose distribution was checked by the Kolmogorov-Smirnov test. Data were analyzed on a per-patient basis for clinical characteristics and on a per-lesion basis for the other analyses. For per-lesion analyses, a generalized estimating equation was used to adjust intrasubject variability among vessels from the same patient. Estimated means and 95% confidence intervals (CIs) were presented as summary statistics. A generalized estimating equation procedure with pairwise comparison was used to compare per-lesion variables. The comparison of 18 F-NaF TBR among the 3 groups were also performed using generalized estimating equation without post hoc adjustment. All probability values were 2 sided, and P<0.05 were considered statistically significant. The SPSS version 18.0 (SPSS Inc, Chicago, IL) and SAS version 9.3 (SAS Institute, Inc, Cary, NC) statistical packages were used for statistical analyses. 18 F-NaF-negative plaques. However, OCT-measured calcium area or maximum calcium arc was not different between 18 F-NaF-positive and 18 F-NaF-negative plaques. In a CCTA subgroup (n=46), the prevalence of noncalcified plaque and the remodeling index measured by CCTA was higher in 18 F-NaF-positive plaques than in 18 F-NaF-negative plaques. There was no difference in the prevalence of plaques with any APC between 18 F-NaFpositive and 18 F-NaF-negative plaques (Table 2) . Among 51 lesions with 18 F-NaF-positive uptake, 48 lesions (94.1%) had at least 1 high-risk feature (Figures 2  and 3) . The 3 lesions without any high-risk feature were all mild stenoses with superficial calcification. The diagnostic performance of 18 F-NaF uptake was different for each highrisk characteristic defined by IVUS and OCT (Table I in Figure 5 ). Among the 15 lesions that met both IVUS-and OCT-defined criteria for high-risk plaque, 14 (93.3%) showed 18 F-NaF-positive uptake. In a subgroup of patients with obesity, the differences in 18 F-NaF TBR and proportion of 18 F-NaF-positive lesions were similar with the total population ( Figure IV in the Data Supplement). In a CCTA subgroup, all high-risk plaques by both IVUS and OCT showed positive 18 F-NaF uptake, but only 44.4% of those plaques had APC by CCTA.
Results
Baseline Characteristics of Patients and Lesions
Discussion
The current study evaluated the clinical relevance of the plaques with 18 F-NaF uptake using IVUS, OCT, and CCTA in a non-myocardial infarction population and the main findings are as follows. First, 18 F-NaF-positive plaques showed more high-risk features in IVUS (positive remodeling, posterior attenuation, or higher plaque burden) and OCT (higher maximum lipid arc and prominent microvessels), compared with 18 F-NaF-negative plaques. There was no difference in lumen area and calcium area. Second, the 18 F-NaF TBR was significantly higher in high-risk plaques defined by IVUS and OCT than in non-high-risk plaques. When the plaques were classified into 3 groups (group 1: non-high-risk plaque, group 2: high-risk plaque by only 1 imaging modality, and group 3: high-risk plaque by both IVUS and OCT), 18 F-NaF TBR was the highest in group 3. Third, there was no difference in the prevalence of plaques with any APC between 18 F-NaFpositive and 18 F-NaF-negative plaques in the CCTA subgroup.
Noninvasive 18 F-NaF PET to Detect High-Risk Plaque
As acute coronary syndrome can cause fatal clinical consequences, it is important to identify the high-risk plaque for future cardiac events. Previous invasive or noninvasive imaging studies showed the association between high-risk plaque characteristics and future clinical events. classical angiographic and clinical risk profiles, invasive or noninvasive detection of plaque with high-risk features has been considered to possess incremental prognostic benefit. 27 Nevertheless, there is still a need for a new imaging target because of the high prevalence of those high-risk features and their low positive predictive values for clinical events. Data were presented with estimated mean with 95% confidence interval, which was calculated using generalized estimating equation, or presented with proportion. 18 F-NaF indicates 18 F-sodium fluoride; CT, computed tomography; IVUS, intravascular ultrasound; MLA, minimum lumen area; OCT, optical coherence tomography; QCA, quantitative coronary angiography; and TCFA, thin-cap fibroatheroma.
*Any of adverse plaque characteristics was defined as "any of low-attenuation plaque, positive remodeling, napkin-ring sign, and spotty calcification."
In this regard, 18 F-NaF PET showed promising results as a noninvasive imaging tool to detect metabolically active plaques with ongoing calcifying activity and vascular inflammation.
12,14 Previously, Joshi et al 12 showed the 18 F-NaF TBR was higher in culprit lesions of acute myocardial infarction than in nonculprit lesions. In patients with stable angina, 15 of 39 plaques showed focal 18 F-NaF uptake and those lesions showed higher remodeling index, more necrotic core, and more frequent microcalcification in virtual-histology IVUS. 12 Despite this promising result, the clinical relevance of 18 F-NaF PET uptake has not been fully investigated with current invasive and noninvasive imaging modalities to define plaque with high-risk characteristics, especially in patients undergoing elective coronary intervention with clinically relevant stenosis. In a study by Joshi et al 12 , median MLA of 18 F-NaF PET uptake positive plaque in the stable angina group was 9.0 mm 2 .
Plaque Characteristics of 18 F-NaF PET-Positive Plaques
In comparison of plaque characteristics between 18 F-NaF-positive and 18 F-NaF-negative lesions, stenosis severity, including quantitative coronary angiography diameter stenosis, IVUS, or OCT MLA, and IVUS area stenosis were not significantly different between the 2 groups. Among the high-risk features measured by IVUS or OCT, 18 F-NaF-positive plaques showed higher plaque burden, remodeling index, maximum lipid arc, and higher prevalence of positive remodeling and prominent microvessels, compared with 18 F-NaF-negative plaques. 18 F-NaF-positive plaques (94.1%) had at least 1 high-risk feature. In contrast, calcium area or maximum calcium arc were not different between 18 F-NaF-positive and 18 F-NaF-negative plaques. These results suggest that 18 F-NaF PET can detect the stage of ongoing calcifying activity or a marker of active inflammation 5, 12, [28] [29] [30] [31] [32] that cannot be identified by conventional invasive imaging modalities. It is interesting to note that the diagnostic performance of 18 F-NaF uptake was different for each high-risk characteristic defined by IVUS or OCT.
It is noteworthy that the prevalence of OCT-defined TCFA or minimum cap thickness was not different between 18 F-NaF-positive and 18 F-NaF-negative plaques in our study. Conversely, 18 F-NaF uptake showed significant association with the presence of microvessel(s) in OCT. Although OCT has been regarded as a gold standard to detect TCFA because of its superior resolution, 22 it needs to be considered that OCT minimum cap thickness is a part of the whole spectrum of high-risk plaque. 33, 34 Our study results show that 18 F-NaF PET uptake is more closely associated with plaque burden and its contents, rather than the cap thickness. Considering that each characteristic from OCT or IVUS reflects a different aspect of plaque vulnerability, 18 F-NaF PET might have a potential complementary role in the detection of a plaque with high-risk characteristics. In our study, 18 F-NaF TBR and the proportion of 18 F-NaF-positive plaques were higher in high-risk plaques, defined by both IVUS and OCT, than those defined by only 1 imaging modality. To date, CCTA has been regarded as a standard noninvasive tool to assess plaque characteristics. 11, 35 In our study, there was no difference in the prevalence of plaques with any APC between 18 F-NaF-positive and 18 F-NaF-negative plaques in the CCTA subgroup. In addition, despite that all high-risk plaques by both IVUS and OCT showed positive 18 F-NaF uptake, only 44.4% of those plaques had APC by CCTA. These results suggest the complementary role of 18 F-NaF PET to CCTA as a noninvasive test to identify a plaque with highrisk characteristics in patients with coronary artery disease.
Limitations
Some limitations of the study should be acknowledged. First, the current study was conducted with a relatively small sample size. The overall findings, especially for the additive value of 18 F-NaF PET to CCTA in noninvasive detection of high-risk plaque, need to be further clarified with a larger patient cohort to ensure generalizability. Second, despite that high-risk plaques were defined using multiple imaging modalities, comparison of 18 F-NaF PET findings with histological characteristics could not be performed. Third, although high-risk features obtained from IVUS, OCT, or CCTA have been shown to be associated with future clinical events, 22, 33 the prognostic implication of 18 F-NaF uptake could not be investigated in our study. Further study is warranted to clarify this issue. Fourth, in the current study, 18 F-NaF-positive plaques could not represent the OCTdefined TCFA. Although OCT or optical frequency domain 18 F-NaF) positron-emission tomography (PET) tissue-to-background ratio (TBR) between intravascular ultrasound (IVUS) or optical coherence tomography (OCT) defined high-versus non-high-risk plaque. In comparison of 18 F-NaF TBR values between high-and non-high-risk plaques, defined by IVUS or OCT criteria, 18 F-NaF TBR values were significantly higher in high-risk plaque using (A) IVUS or (B) OCT, compared with non-high-risk plaques. IVUS-defined high-risk plaque was defined as a plaque with both posterior attenuation and positive remodeling. OCT-defined high-risk plaque was defined as a plaque with thin-cap fibroatheroma (TCFA), macrophage(s), or microvessel(s).
Figure 5.
Comparison of tissue-to-background ratio (TBR) or positive uptake of 18 F-sodium fluoride ( 18 F-NaF) positron-emission tomography (PET) among 3 groups classified according to intravascular ultrasound (IVUS) or optical coherence tomography (OCT) defined highrisk plaques. The 73 lesions evaluated with both IVUS and OCT were classified into 3 groups according to presence of high-risk plaque by IVUS or OCT. Among group 1 (non-high-risk plaque by both IVUS and OCT), group 2 (high-risk plaque only in 1 imaging modality), and group 3 (high-risk plaque by both IVUS and OCT), group 3 showed the highest 18 F-NaF TBR value and highest proportion of 18 F-NaF positive lesions, compared with the other groups. *P<0.05 n.s. indicates no significance.
imaging itself also showed limited diagnostic accuracy to detect pathologically diagnosed TCFA, 36, 37 this might also limited role of 18 F-NaF PET to detect OCT-defined TCFA.
Conclusions
The results of this study suggest that 18 F-NaF PET can be a useful noninvasive diagnostic tool to identify and localize the plaque with high-risk characteristics in patients with coronary artery disease.
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